Search press releases
Every release here is real and links to its original. Filter by company, topic, language and date.
- HIMS DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the “Class Period”), of the important November 2, 2026 lead plaintiff deadline.
- Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity-- Launch follows MHLW approval of IMCIVREE for acquired hypothalamic obesity and inclusion on Japan's National Health Insurance drug price list -- -- IMCIVREE is the first approved therapy in Japan for patients living with acquired hypothalamic obesity --
- Orum Therapeutics Doses First Patient in Phase 1 Trial of ORM-1153, a CD123-GSPT1 Degrader-Antibody ConjugateOrum announced that the first patient has been dosed in a Phase 1 clinical trial evaluating ORM-1153, the Company’s investigational CD123-GSPT1 DAC.
- Osara HealthOsara Health and Medibank partner to bring one-on-one cancer coaching to membersFrom 14 October, eligible Medibank members living with cancer can access Osara Health's Cancer Coach program for personalised support with the physical and emotional challenges of diagnosis and treatment. SYDNEY, Oct. 13, 2026 -- Osara Health has partnered with Medibank, one...
- PA Health & WellnessPA Health & Wellness Earns National Recognition Among Top Medicaid Health Plans for Second Consecutive YearPA Health & Wellness, a leading managed care organization in Pennsylvania and a company of Centene Corporation (NYSE: CNC), today announced that it has been recognized among the top 17 Medicaid health plans in the United States by the...
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHPomerantz LLP is investigating claims on behalf of investors of Astrana Health, Inc. (“Astrana” or the “Company”) (NASDAQ: ASTH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
- Cincinnati Children's Hospital Medical Center10 Research Opportunities Poised to Advance Child HealthCincinnati Children's research leader Tina Cheng, MD, MPH, and colleagues identify priority areas that could transform health—not just during childhood, but across the lifespan — Ten areas of pediatric research could drive the next generation of...
- Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic DiseasesCollaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multispecific drug candidates with tailored biological functions
- Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic DiseasesPress release – No. 20 / 2026
- Kaplan Fox & Kilsheimer LLPKaplan Fox & Kilsheimer LLP Alerts Hims & Hers Health, Inc. (HIMS) Investors: Securities Class Action Deadline is November 2, 2026Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 2025 and July 29, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Hims & Hers and have suffered losses, you may CLICK HERE to contact us. You may also...
- Medical Solutions LLCMedical Solutions CEO Rebecca Rogers Tijerino named to SIA's 2026 Global Power 150 Women in Staffing listMedical Solutions, one of the nation's leading healthcare workforce solutions partners, congratulates CEO Rebecca Rogers Tijerino for being named to Staffing Industry Analysts' 2026 Global Power 150 Women in Staffing list. The annual list...
- Mercy Medical CenterMercy Medical Center Expands Prostate Cancer Treatment Options With Advanced TrueBeam TechnologyMercy Medical Center is expanding advanced treatment options for men with prostate cancer through the enhanced capabilities of its Varian TrueBeam radiotherapy system, providing appropriately selected patients with access to highly precise...